Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria CH Polman, SC Reingold, B Banwell, M Clanet, JA Cohen, M Filippi, ... Annals of neurology 69 (2), 292-302, 2011 | 11118 | 2011 |
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria AJ Thompson, BL Banwell, F Barkhof, WM Carroll, T Coetzee, G Comi, ... The Lancet Neurology 17 (2), 162-173, 2018 | 7287 | 2018 |
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” CH Polman, SC Reingold, G Edan, M Filippi, HP Hartung, L Kappos, ... Annals of Neurology: Official Journal of the American Neurological …, 2005 | 6668 | 2005 |
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. F Barkhof, M Filippi, DH Miller, P Scheltens, A Campi, CH Polman, ... Brain: a journal of neurology 120 (11), 2059-2069, 1997 | 1813 | 1997 |
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study G Comi, M Filippi, F Barkhof, L Durelli, G Edan, O Fernández, HP Hartung, ... The Lancet 357 (9268), 1576-1582, 2001 | 1487 | 2001 |
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines M Filippi, MA Rocca, O Ciccarelli, N De Stefano, N Evangelou, L Kappos, ... The Lancet Neurology 15 (3), 292-303, 2016 | 1075 | 2016 |
European/Canadian multicenter, double‐blind, randomized, placebo‐controlled study of the effects of glatiramer acetate on magnetic resonance imaging–measured disease activity … G Comi, M Filippi, JS Wolinsky, ... Annals of neurology 49 (3), 290-297, 2001 | 1056 | 2001 |
Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis D Miller, F Barkhof, X Montalban, A Thompson, M Filippi The Lancet Neurology 4 (5), 281-288, 2005 | 960 | 2005 |
Differential diagnosis of suspected multiple sclerosis: a consensus approach DH Miller, BG Weinshenker, M Filippi, BL Banwell, JA Cohen, ... Multiple Sclerosis Journal 14 (9), 1157-1174, 2008 | 935 | 2008 |
White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging M Bozzali, A Falini, M Franceschi, M Cercignani, M Zuffi, G Scotti, G Comi, ... Journal of Neurology, Neurosurgery & Psychiatry 72 (6), 742-746, 2002 | 801 | 2002 |
Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind … G Comi, V Martinelli, M Rodegher, L Moiola, O Bajenaru, A Carra, ... The Lancet 374 (9700), 1503-1511, 2009 | 792 | 2009 |
Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis M Calabrese, F Agosta, F Rinaldi, I Mattisi, P Grossi, A Favaretto, M Atzori, ... Archives of neurology 66 (9), 1144-1150, 2009 | 766 | 2009 |
Association between pathological and MRI findings in multiple sclerosis M Filippi, W Brück, D Chard, F Fazekas, JJG Geurts, C Enzinger, ... The Lancet Neurology 18 (2), 198-210, 2019 | 704 | 2019 |
Diffusion tensor magnetic resonance imaging in multiple sclerosis M Filippi, M Cercignani, M Inglese, MA Horsfield, G Comi Neurology 56 (3), 304-311, 2001 | 685 | 2001 |
Resting state fMRI in Alzheimer's disease: beyond the default mode network F Agosta, M Pievani, C Geroldi, M Copetti, GB Frisoni, M Filippi Neurobiology of aging 33 (8), 1564-1578, 2012 | 649 | 2012 |
Automated classification of Alzheimer's disease and mild cognitive impairment using a single MRI and deep neural networks S Basaia, F Agosta, L Wagner, E Canu, G Magnani, R Santangelo, ... NeuroImage: Clinical 21, 101645, 2019 | 633 | 2019 |
Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis MA Rocca, MP Amato, N De Stefano, C Enzinger, JJ Geurts, IK Penner, ... The Lancet Neurology 14 (3), 302-317, 2015 | 626 | 2015 |
Evidence of early cortical atrophy in MS: relevance to white matter changes and disability N De Stefano, PM Matthews, M Filippi, F Agosta, M De Luca, ... Neurology 60 (7), 1157-1162, 2003 | 612 | 2003 |
Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled … L Kappos, G Comi, H Panitch, J Oger, J Antel, P Conlon, L Steinman, ... Nature medicine 6 (10), 1176-1182, 2000 | 609 | 2000 |
Cognition in multiple sclerosis: State of the field and priorities for the future JF Sumowski, R Benedict, C Enzinger, M Filippi, JJ Geurts, P Hamalainen, ... Neurology 90 (6), 278-288, 2018 | 594 | 2018 |